{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:53:11Z","timestamp":1785804791824,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019578","name":"Changi General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019578","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Familial partial lipodystrophy (FPLD) is an inherited disorder of white adipose tissue that causes premature cardiometabolic disease. There is no clear diagnostic criteria for FPLD, and this may explain the under-detection of this condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>This pilot study aimed to describe the clinical features of women with FPLD and to explore the value of adipose tissue measurements that could be useful in diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In 8 women with FPLD and 4 controls, skinfold measurements, DXA and whole-body MRI were undertaken.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Whole genome sequencing was negative for monogenic metabolic causes, but polygenic scores for partial lipodystrophy were elevated in keeping with FPLD type 1. The mean age of diagnosis of DM was 31 years in the FPLD group. Compared with controls, the FPLD group had increased HOMA-IR (10.3 vs 2.9, <jats:italic>p<\/jats:italic>\u2009=\u20090.028) and lower mean thigh skinfold thickness (19.5\u2009mm vs 48.2\u2009mm, <jats:italic>p<\/jats:italic>\u2009=\u20090.008). The FPLD group had lower percentage of leg fat and an increased ratio of trunk to leg fat percentage on DXA. By MRI, the FPLD group had decreased subcutaneous adipose tissue (SAT) volume in the femoral and calf regions (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01); abdominal SAT, visceral adipose tissue, and femoral and calf muscle volumes were not different from controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Women with FPLD1 in Singapore have significant loss of adipose but not muscle tissue in lower limbs and have early onset of diabetes. Reduced thigh skinfold, and increased ratio of trunk to leg fat percentage on DXA are potentially clinically useful markers to identify FPLD1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-024-00260-y","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:02:06Z","timestamp":1707246126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and imaging features of women with polygenic partial lipodystrophy: a case series"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-907X","authenticated-orcid":false,"given":"Wann Jia","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadegoud","family":"Yaligar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-1288","authenticated-orcid":false,"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Anand","family":"Sadananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshe","family":"Kway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1742-5817","authenticated-orcid":false,"given":"Su Chi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald.F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambasivam Sendhil","family":"Velan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-5889","authenticated-orcid":false,"given":"Melvin Khee Shing","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"260_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","volume":"19","author":"Y Handelsman","year":"2013","unstructured":"Handelsman Y, Oral EA, Bloomgarden ZT, Brown RJ, Chan JL, Einhorn D, et al. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract. 2013;19:107\u201316.","journal-title":"Endocr Pract."},{"key":"260_CR2","first-page":"111","volume":"29","author":"J Kobberling","year":"1975","unstructured":"Kobberling J, Willms B, Kattermann R, Creutzfeldt W. Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik 1975;29:111\u201320.","journal-title":"Humangenetik"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","volume":"26","author":"KL Herbst","year":"2003","unstructured":"Herbst KL, Tannock LR, Deeb SS, Purnell JQ, Brunzell JD, Chait A. Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 2003;26:1819\u201324.","journal-title":"Diabetes Care"},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1172\/JCI129190","volume":"129","author":"JP Mann","year":"2019","unstructured":"Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest. 2019;129:4009\u201321.","journal-title":"J Clin Invest."},{"key":"260_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/cen.13311","volume":"86","author":"N Ajluni","year":"2017","unstructured":"Ajluni N, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, et al. Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf) 2017;86:698\u2013707.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","volume":"51","author":"I Hussain","year":"2019","unstructured":"Hussain I, Patni N, Garg A. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease. Pathology 2019;51:202\u201312.","journal-title":"Pathology"},{"key":"260_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.metabol.2017.04.010","volume":"72","author":"B Akinci","year":"2017","unstructured":"Akinci B, Onay H, Demir T, Savas-Erdeve S, Gen R, Simsir IY, et al. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy. Metabolism 2017;72:109\u201319.","journal-title":"Metabolism"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1210\/clinem\/dgac079","volume":"107","author":"LT Fourman","year":"2022","unstructured":"Fourman LT, Grinspoon SK. Approach to the patient with lipodystrophy. J Clin Endocrinol Metab. 2022;107:1714\u201326.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR9","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2337\/dc18-0978","volume":"41","author":"R Meral","year":"2018","unstructured":"Meral R, Ryan BJ, Malandrino N, Jalal A, Neidert AH, Muniyappa R, et al. Fat Shadows\u201d From DXA for the qualitative assessment of lipodystrophy: when a picture is worth a thousand numbers. Diabetes Care 2018;41:2255\u20138.","journal-title":"Diabetes Care"},{"key":"260_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-4-40","volume":"4","author":"CM Valerio","year":"2012","unstructured":"Valerio CM, Zajdenverg L, de Oliveira JE, Mory PB, Moyses RS, Godoy-Matos AF. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012;4:40.","journal-title":"Diabetol Metab Syndr."},{"key":"260_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5152\/dir.2017.17019","volume":"23","author":"C Altay","year":"2017","unstructured":"Altay C, Secil M, Demir T, Atik T, Akinci G, Ozdemir Kutbay N, et al. Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy. Diagn Inter Radiol. 2017;23:428\u201334.","journal-title":"Diagn Inter Radiol."},{"key":"260_CR12","first-page":"170","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 1999;84:170\u20134.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR13","doi-asserted-by":"publisher","first-page":"W602","DOI":"10.2214\/AJR.11.8110","volume":"199","author":"PD McLaughlin","year":"2012","unstructured":"McLaughlin PD, Ryan J, Hodnett PA, O\u2019Halloran D, Maher MM. Quantitative whole-body MRI in familial partial lipodystrophy type 2: changes in adipose tissue distribution coincide with biochemical improvement. Am J Roentgenol. 2012;199:W602\u20136.","journal-title":"Am J Roentgenol."},{"key":"260_CR14","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101:4500\u201311.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR15","unstructured":"Marfell-Jones MJ, Stewart A, De Ridder J. International standards for anthropometric assessment (2012)."},{"key":"260_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"260_CR17","doi-asserted-by":"publisher","first-page":"e200304","DOI":"10.1148\/ryai.2021200304","volume":"3","author":"YM Kway","year":"2021","unstructured":"Kway YM, Thirumurugan K, Tint MT, Michael N, Shek LP, Yap FKP, et al. Automated segmentation of visceral, deep subcutaneous, and superficial subcutaneous adipose tissue volumes in MRI of neonates and young children. Radio Artif Intell. 2021;3:e200304.","journal-title":"Radio Artif Intell."},{"key":"260_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2337\/diabetes.52.2.244","volume":"52","author":"A Kautzky-Willer","year":"2003","unstructured":"Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S, et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003;52:244\u201351.","journal-title":"Diabetes"},{"key":"260_CR19","doi-asserted-by":"publisher","first-page":"e4266","DOI":"10.1002\/nbm.4266","volume":"34","author":"M Krssak","year":"2021","unstructured":"Krssak M, Lindeboom L, Schrauwen-Hinderling V, Szczepaniak LS, Derave W, Lundbom J, et al. Proton magnetic resonance spectroscopy in skeletal muscle: Experts\u2019 consensus recommendations. NMR Biomed. 2021;34:e4266.","journal-title":"NMR Biomed."},{"key":"260_CR20","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1210\/clinem\/dgad063","volume":"108","author":"SC Adiyaman","year":"2023","unstructured":"Adiyaman SC, Altay C, Kamisli BY, Avci ER, Basara I, Simsir IY, et al. Pelvis magnetic resonance imaging to diagnose familial partial lipodystrophy. J Clin Endocrinol Metab. 2023;108:e512\u2013e20.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.3714","volume":"49","author":"LA Lotta","year":"2017","unstructured":"Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2017;49:17\u201326.","journal-title":"Nat Genet."},{"key":"260_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00789-4","volume":"21","author":"N Salari","year":"2021","unstructured":"Salari N, Darvishi N, Mansouri K, Ghasemi H, Hosseinian-Far M, Darvishi F, et al. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocr Disord. 2021;21:125.","journal-title":"BMC Endocr Disord."},{"key":"260_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 2018;67:1348\u201359.","journal-title":"Hepatology"},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/dc07-9921","volume":"30","author":"S Klein","year":"2007","unstructured":"Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America\u2019s health: association for weight management and obesity prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 2007;30:1647\u201352.","journal-title":"Diabetes Care"},{"key":"260_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13098-018-0375-9","volume":"10","author":"AF Godoy-Matos","year":"2018","unstructured":"Godoy-Matos AF, Valerio CM, Moreira RO, Momesso DP, Bittencourt LK. Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy. Diabetol Metab Syndr. 2018;10:71.","journal-title":"Diabetol Metab Syndr."},{"key":"260_CR26","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1210\/jc.2008-1585","volume":"93","author":"MD Jensen","year":"2008","unstructured":"Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93:S57\u201363.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","volume":"96","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Perakakis N, Mantzoros CS. Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement. Metabolism 2019;96:66\u201382.","journal-title":"Metabolism"},{"key":"260_CR28","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/jama.2018.19329","volume":"320","author":"LA Lotta","year":"2018","unstructured":"Lotta LA, Wittemans LBL, Zuber V, Stewart ID, Sharp SJ, Luan J, et al. Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors. JAMA 2018;320:2553\u201363.","journal-title":"JAMA"},{"key":"260_CR29","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1210\/jc.2006-0015","volume":"91","author":"S Shadid","year":"2006","unstructured":"Shadid S, Stehouwer CDA, Jensen MD. Diet\/exercise versus pioglitazone: effects of insulin sensitization with decreasing or increasing fat mass on adipokines and inflammatory markers. J Clin Endocrinol Metab. 2006;91:3418\u201325.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","volume":"54","author":"C Guillin-Amarelle","year":"2016","unstructured":"Guillin-Amarelle C, Sanchez-Iglesias S, Castro-Pais A, Rodriguez-Canete L, Ordonez-Mayan L, Pazos M, et al. Type 1 familial partial lipodystrophy: understanding the Kobberling syndrome. Endocrine 2016;54:411\u201321.","journal-title":"Endocrine"},{"key":"260_CR31","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1210\/clinem\/dgaa137","volume":"105","author":"C Vasandani","year":"2020","unstructured":"Vasandani C, Li X, Sekizkardes H, Adams-Huet B, Brown RJ, Garg A. Diagnostic value of anthropometric measurements for familial partial lipodystrophy, dunnigan variety. J Clin Endocrinol Metab. 2020;105:2132\u201341.","journal-title":"J Clin Endocrinol Metab."},{"key":"260_CR32","doi-asserted-by":"publisher","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","volume":"4","author":"TL Kelly","year":"2009","unstructured":"Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE 2009;4:e7038.","journal-title":"PLoS ONE"},{"key":"260_CR33","doi-asserted-by":"publisher","first-page":"e0276434","DOI":"10.1371\/journal.pone.0276434","volume":"17","author":"BP Soh","year":"2022","unstructured":"Soh BP, Lee SY, Wong WY, Pang BWJ, Lau LK, Jabbar KA, et al. Body composition reference values in Singaporean adults using dual-energy X-ray absorptiometry-The Yishun study. PLoS ONE 2022;17:e0276434.","journal-title":"PLoS ONE"},{"key":"260_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13105-015-0404-1","volume":"71","author":"VA Cortes","year":"2015","unstructured":"Cortes VA, Fernandez-Galilea M. Lipodystrophies: adipose tissue disorders with severe metabolic implications. J Physiol Biochem. 2015;71:471\u20138.","journal-title":"J Physiol Biochem."}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00260-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:02:17Z","timestamp":1707246137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00260-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1038\/s41387-024-00260-y","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"6 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.J.L. has received honoraria from Medtronic, Abbott, DKSH, and Novartis. G.F.W. has received honoraria for advisory boards and research grants from Amgen, Arrowhead, Esperion, AstraZeneca, Kowa, Novartis, Pfizer, Sanofi, and Regeneron. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}